相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The ST2/Interleukin-33 Axis in Hematologic Malignancies: The IL-33 Paradox
Alessandro Allegra et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family
Corinne Cayrol et al.
IMMUNOLOGICAL REVIEWS (2018)
The Role of IL-33/ST2 Pathway in Tumorigenesis
Kristen M. Larsen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Immune Mechanisms in Myelodysplastic Syndrome
Andreas Glenthoj et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Interleukin 33 is a guardian of barriers and a local alarmin
Nikolas T. Martin et al.
NATURE IMMUNOLOGY (2016)
Role of interleukin-6 in cancer progression and therapeutic resistance
Neeraj Kumari et al.
TUMOR BIOLOGY (2016)
Interleukin-33 in health and disease
Foo Yew Liew et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Correlation and Significance of Urinary Soluble Fas and Vascular Endothelial Growth Factor in Bladder Urothelial Cancer
Huixiang Yang et al.
DISEASE MARKERS (2015)
Interleukin-33 in Tissue Homeostasis, Injury, and Inflammation
Ari B. Molofsky et al.
IMMUNITY (2015)
Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes
I. Ganan-Gomez et al.
LEUKEMIA (2015)
Polymorphisms of DNA repair genes are related to the pathogenesis of myelodysplastic syndrome
Howard Lopes Ribeiro Junior et al.
HEMATOLOGICAL ONCOLOGY (2015)
Reduction in IL-33 Plasma Levels Might Be Involved in T Cell Dysregulation in Chronic Lymphocytic Leukemia
Caterina Musolino et al.
ACTA HAEMATOLOGICA (2014)
Serum soluble ST2 is associated with ER-positive breast cancer
Da-peng Lu et al.
BMC CANCER (2014)
Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells
Ivan P. Jovanovic et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
IL-6 and related cytokines as the critical lynchpins between inflammation and cancer
Koji Taniguchi et al.
SEMINARS IN IMMUNOLOGY (2014)
Significance of interleukin-33 and its relatec cytokines in patients with breast cancers
Jing Liu et al.
FRONTIERS IN IMMUNOLOGY (2014)
Reduced IL-33 plasma levels in multiple myeloma patients are associated with more advanced stage of disease
Caterina Musolino et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Decreased Plasma Levels of IL-33 Could Contribute to the Altered Function of Th2 Lymphocytes in Patients with Polycythemia Vera and Essential Thrombocythemia
Sebastiano Gangemi et al.
CANCER INVESTIGATION (2013)
Revised International Prognostic Scoring System for Myelodysplastic Syndromes
Peter L. Greenberg et al.
BLOOD (2012)
Interleukin-6 signaling pathway in targeted therapy for cancer
Yuqi Guo et al.
CANCER TREATMENT REVIEWS (2012)
ST2 deletion enhances innate and acquired immunity to murine mammary carcinoma
Ivan Jovanovic et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
分享论文
